SB 5B contains Saccharomyces cerevisiae (boulardii), a beneficial yeast specifically formulated to support gut-associated lymphoid tissue (GALT) function. GALT represents approximately 70% of your body's immune defenses and plays a crucial role in protecting against pathogens while maintaining tolerance to beneficial bacteria and food particles. When GALT function becomes impaired, it can lead to chronic digestive disturbances, recurrent infections, and systemic inflammatory responses.

Saccharomyces boulardii (SB) offers comprehensive immunological support that extends far beyond typical probiotic benefits. This beneficial yeast acts as an immune agent in itself, specifically targeting key mechanisms within the GALT system. SB increases the production of short-chain fatty acids (SCFAs) such as butyrate, which has been shown to induce intestinal epithelial cell secretion of mucus constituents, including bacteriocins and antimicrobial peptides that support immune function in the GALT [38]. This enhanced mucus production is critical as it provides housing for secretory IgA, the gut's primary immune antibody.

On an immunological level, SB directly stimulates the production of secretory immunoglobulin A (sIgA), a critical component of mucosal immunity that enhances the host's defense against microbial toxins and helps prevent pathogen colonization [38]. This is particularly important given that impaired GALT is often characterized by low levels of sIgA, leaving the digestive tract vulnerable to chronic infections and microbial imbalances.

SB also produces anti-inflammatory factors that modulate immune responses and maintain mucosal homeostasis, helping to break the cycle of chronic inflammation that often perpetuates GALT dysfunction [38]. By supporting both the structural integrity of the gut barrier and the functional capacity of immune responses, SB addresses multiple aspects of impaired GALT simultaneously, making it an ideal therapeutic intervention for those experiencing chronic digestive disturbances, recurrent infections, and related systemic health challenges.